Enquiry/Quote
Rabeprazole Sodium / Levosulpiride Injection bulk supplier for pharma manufacturers

Rabeprazole Sodium / Levosulpiride Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 20mg + 75mg

Reference Brands: Rabeloc Plus (India/LATAM)

Category: Gastrointestinal Drugs

Levosulpiride + Rabeprazole is used in the treatment of gastroesophageal reflux disease (acid reflux), intestinal ulcers and irritable bowel syndrome. Rabeprazole Sodium / Levosulpiride Injection is available in Injection and strengths such as 20mg + 75mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Rabeprazole Sodium / Levosulpiride Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Rabeprazole Sodium / Levosulpiride Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Rabeprazole Sodium (20 mg) and Levosulpiride (75 mg) is a potent combination capsule/tablet formulated to provide comprehensive relief from acid-related gastrointestinal disorders. This medication is primarily used to manage gastroesophageal reflux disease (GERD), acidity, heartburn, and indigestion. By combining two complementary actions, it addresses both excess stomach acid and impaired gastric motility.

Rabeprazole Sodium, a proton pump inhibitor, works by blocking the acid-producing pumps in the stomach lining, thereby reducing gastric acid secretion and alleviating symptoms such as heartburn, regurgitation, and esophageal irritation. Levosulpiride, a prokinetic agent, enhances gastrointestinal motility and accelerates gastric emptying, which helps relieve bloating, nausea, and vomiting.

Typically prescribed to be taken once daily on an empty stomach before meals, this combination provides rapid and effective symptom control while promoting better digestive health. It is especially useful for patients who experience persistent acidity, delayed gastric emptying, or related gastrointestinal discomfort. When used under medical supervision, Rabeprazole Sodium and Levosulpiride capsules/tablets offer a convenient and reliable solution for managing chronic and acute digestive disorders.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Rabeprazole Sodium / Levosulpiride is a combination medication used to treat acid-related gastrointestinal disorders such as gastroesophageal reflux disease (GERD), acidity, heartburn, indigestion, bloating, and nausea. Rabeprazole, a proton pump inhibitor, reduces stomach acid production, while Levosulpiride, a prokinetic agent, improves gastric motility and helps relieve nausea and vomiting. This combination provides comprehensive relief from both acid-related irritation and delayed gastric emptying.

It is made from Rabeprazole Sodium, a proton pump inhibitor that blocks acid-producing pumps in the stomach lining, and Levosulpiride, a dopamine D2 receptor antagonist that enhances gastrointestinal motility and controls nausea.

Common trade names include Rabeloc‑M, Rabimed‑L, Rabesulp, Rabep‑L, and Levosrab.

This combination is manufactured by various pharmaceutical companies in India, including Sun Pharma, Torrent Pharmaceuticals, Abbott, Alkem Laboratories, Cipla, and Intas Pharmaceuticals, depending on the brand.

The generic name is Rabeprazole Sodium Levosulpiride Tablet.

Brand names include Rabeloc‑M, Rabimed‑L, Rabesulp, Rabep‑L, and Levosrab.

These tablets are primarily manufactured in India and exported to regions such as Asia, Africa, and Latin America, depending on regulatory approvals and market demand.

Yes, Rabeprazole Sodium / Levosulpiride Injection is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Rabeprazole Sodium / Levosulpiride Injection is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Bismuth Subsalicylate

Strength:
262 mg, 525 mg

Form: Oral suspension / Tablet

Reference Brands: Pepto-Bismol (USA/LATAM),

View Details
Plecanatide

Strength:
3 mg

Form: Tablets

Reference Brands: Trulance (USA)

View Details
Naldemedine

Strength:
0.2 mg

Form: Tablets

Reference Brands: Symproic (USA/EU)

View Details
Resmetirom

Strength:
80 mg ,100 mg

Form: Tablets

Reference Brands: Rezdiffra (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.